Home Tools
Log in
Cart

Decarboxylase

Carboxy-lyases, also known as decarboxylases, are carbon–carbon lyases that add or remove a carboxyl group from organic compounds. These enzymes catalyze the decarboxylation of amino acids, beta-keto acids and alpha-keto acids.
Cat. No. Product name CAS No. Purity Chemical Structure
T17166 Tritoqualine 14504-73-5 98%
Tritoqualine is used as an inhibitor of histidine decarboxylase.
T7454 4-Bromo-3-hydroxybenzoic acid 14348-38-0 98%
4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase.
T6795 Carbidopa 28860-95-9 98%
Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
T2148 Carbidopa monohydrate 38821-49-7 98%
Carbidopa Hydrate is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.
T2593 Eflornithine hydrochloride hydrate 96020-91-6 98%
Eflornithine hydrochloride is a specific, irreversible inhibitor of ornithine decarboxylase.
T0737 L-Ornithine 70-26-8 98%
L-ornithine has an anti-fatigue function in facilitating the excretion of ammonia and increasing the efficiency of energy consumption.
Tritoqualine
T17166
Tritoqualine is used as an inhibitor of histidine decarboxylase.
4-Bromo-3-hydroxybenzoic acid
T7454
4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase.
Carbidopa
T6795
Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
Carbidopa monohydrate
T2148
Carbidopa Hydrate is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.
Eflornithine hydrochloride hydrate
T2593
Eflornithine hydrochloride is a specific, irreversible inhibitor of ornithine decarboxylase.
L-Ornithine
T0737
L-ornithine has an anti-fatigue function in facilitating the excretion of ammonia and increasing the efficiency of energy consumption.